Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of OSI-211 Vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
This study has been completed.
Study NCT00046800   Information provided by OSI Pharmaceuticals
First Received: October 3, 2002   Last Updated: June 23, 2005   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study has been completed.
  Estimated Study Completion Date: March 2003
  Estimated Primary Completion Date: No date given